Abdelrahman Ibrahim Abushouk: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 9: Line 9:
* Postdoctoral Research Fellow at PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
* Postdoctoral Research Fellow at PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
* Associate Editor-in-Chief at WikiDoc Foundation (WikiDoc.org)
* Associate Editor-in-Chief at WikiDoc Foundation (WikiDoc.org)
* Guest Executive Editor, Current Pharmaceutical Design, Bentham Science Publishers, UAE
*Review Editor, Frontiers in Cardiovascular Medicine (Cardio-Oncology Section), Frontiers Publishers, Switzerland.
*Review Editor, Frontiers in Cardiovascular Medicine (Cardio-Oncology Section), Frontiers Publishers, Switzerland.


Line 19: Line 18:
* Through basic research, we uncovered the value of some therapeutics as diosmin, fucoidan, metformin, and telmisartan in preventing chemotherapy-induced cardiotoxicity.
* Through basic research, we uncovered the value of some therapeutics as diosmin, fucoidan, metformin, and telmisartan in preventing chemotherapy-induced cardiotoxicity.
* Research cited in 12 national/international guidelines, drug updates, and state policies.
* Research cited in 12 national/international guidelines, drug updates, and state policies.
*Overall, my research was cited about 800 times according to Google Scholar and 600 times according to Scopus Database (h-index: 13-16).
*Overall, my research was cited about 800 times according to Google Scholar (h-index: 17) and 600 times according to Scopus Database (h-index: 14).
* More than 30 papers listed by the NICE Guidelines website as reliable sources of evidence.
* More than 30 papers listed by the NICE Guidelines website as reliable sources of evidence.
* Research covered in Scientific American and Atlas of Science magazine.
* Research covered in Scientific American and Atlas of Science magazine.
Line 66: Line 65:


*[[Dilated cardiomyopathy|Dilated Cardiomyopathy]]
*[[Dilated cardiomyopathy|Dilated Cardiomyopathy]]
*[[Dressler's syndrome|Dressler's Syndrome]]  
*[[Supraventricular tachycardia]]
*[[Eisenmenger's syndrome|Eisenmenger's Syndrome]]
*[[Dressler's syndrome|Dressler's Syndrome]]
*[[Beriberi]]
*[[Beriberi]]
*[[Eisenmenger's syndrome|Eisenmenger's Syndrome]]

Revision as of 13:59, 27 January 2020

Abdelrahman I. Abushouk, MD I Email: Aabushou@bidmc.harvard.edu

Education

  • Bachelor of Medicine and Surgery (MBBCh), Faculty of Medicine, Ain Shams University, Cairo, Egypt. I officially graduated with Excellence with Honors in June 2016 (Among top Class Graduates; Summa Cum Laude).

Current Position

  • Postdoctoral Research Fellow at PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Associate Editor-in-Chief at WikiDoc Foundation (WikiDoc.org)
  • Review Editor, Frontiers in Cardiovascular Medicine (Cardio-Oncology Section), Frontiers Publishers, Switzerland.

Research Impact

  • My research has shown the value of iFR and MD-CT in the assessment of challenging coronary lesions (bifurcation and chronic total occlusion).
  • Our research established the non-inferiority of TAVR to SAVR in low-to-moderate risk patients with aortic stenosis and compared the outcomes of different valves.
  • In cardio-oncology, we assessed the burden of cardiac tumors, cancer-related cardiac death, and effects of cancer on PCI outcomes.
  • Through basic research, we uncovered the value of some therapeutics as diosmin, fucoidan, metformin, and telmisartan in preventing chemotherapy-induced cardiotoxicity.
  • Research cited in 12 national/international guidelines, drug updates, and state policies.
  • Overall, my research was cited about 800 times according to Google Scholar (h-index: 17) and 600 times according to Scopus Database (h-index: 14).
  • More than 30 papers listed by the NICE Guidelines website as reliable sources of evidence.
  • Research covered in Scientific American and Atlas of Science magazine.

Awards, Grants, and Scholarships

  1. Nominee for Fulbright Award 2018 - Binational Fulbright Commission in Egypt, Cairo, Egypt
  2. Research Support Grant - Deanship of Scientific Research, King Faisal University, SA (Grant No. 160021)
  3. Research Support Grant - Deanship of Scientific Research, King Saud University, SA (Grant No. RGP-018)
  4. Excellence and Scholastic Outstanding Achievement Award (For ranking among the top students in my Bachelor Degree Class), Ain Shams University, Cairo, Egypt (March 2016).
  5. Publons Peer Review Awards (Publons – Clarivate Analytics®): In 2018 and 2019 in the fields of Clinical Medicine (Global rank: 2) and Biochemistry and Molecular Biology (Global rank: 22).
  6. Best Poster Presentation Award - American College of Cardiology Conference (Sep, 2017, Riyadh, KSA); 5000 USD and the abstract is published under the Best Posters Section of JACC.
  7. Young Investigator Award - 11th World Stroke Congress 2018, World Stroke Federation (Montreal, Canada). The abstract is now published in the International Journal of Stroke.
  8. IBRO Full Scholarships (travel, accommodation and training) on immunohistochemistry and confocal microscopy (Cape Town University, SA & Mohamed V University, Morocco).

Peer-reviewed Publications

  1. Outcomes of Direct Flow Medical vs Sapien 3 Transcatheter Aortic Valve Devices. J Cardiovasc Transl Res. 2019. PMID: 31848880.
  2. Temporal trends, ethnic determinants, and short-term and long-term risk of cardiac death in cancer patients: a cohort study. Cardiovasc Pathol. 2019; 43:107147. PMID: 31494524.
  3. Characteristics, survival and incidence rates and trends of primary cardiac malignancies in the United States. Cardiovasc Pathol. 2018. PMID: 29414429.
  4. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study. Curr Probl Cancer. 2019. PMID: 30195804.
  5. Diagnostic accuracy of multi-slice computed tomography in identifying lesion characteristics in coronary total occlusion. Int J Cardiovasc Imaging. 2018. PMID: 29948635.
  6. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using instantaneous wave-free ratio. Indian Heart J. 2018. PMID: 30595269.
  7. Correlation of central venous pressure with venous blood gas analysis parameters; a diagnostic study. J Emerg Med. 2017. PMID: 28345066.
  8. Awareness of Basic Life Support among Egyptian Medical Students; a Cross-Sectional Study. Emerg. 2018. PMID: 30009238.
  9. Fib-4 Predicts Early Hematological Adverse Events Induced by Interferon-Based Triple Therapy in Chronic Hepatitis C Virus Patients. J Interferon Cytokine Res. 2019. PMID: 30657408.
  10. Fucoidan alleviates microcystin-LR-induced hepatic, renal, and cardiac oxidative stress and inflammatory injuries in mice. Environ Sci Pollut Res. 2019. PMID: 31838672.
  11. Diosmin Attenuates Methotrexate-Induced Hepatic, Renal, and Cardiac Injury: A Biochemical and Histopathological Study in Mice. Oxid Med Cell Longev. 2017. PMID: 28819543.
  12. The effects of abamectin on oxidative stress and gene expression in rat liver and brain tissues: Modulation by sesame oil and ascorbic acid. Sci Total Environ. 2020. PMID: 31739238.
  13. Antagonistic effects of Spirulina platensis on diazinon-induced hemato-biochemical alterations and oxidative stress in rats. Environ Sci Pollut Res. 2018. PMID: 30043347.
  14. The nephroprotective effects of allicin and ascorbic acid against cisplatin-induced toxicity in rats. Environ Sci Pollut Res. 2019. PMID: 30911969.
  15. Nephroprotective Effects of Benzyl Isothiocyanate and Resveratrol Against Cisplatin-Induced Oxidative Stress and Inflammation. Front Pharmacol. 2018. PMID: 30524274.
  16. Thymoquinone and diallyl sulfide protect against fipronil-induced oxidative injury in rats. Environ Sci Pollut Res. 2018. PMID: 29881965.
  17. Tobacco smoking in Egypt: a scoping literature review of its epidemiology and control measures. East Mediterr Health J. 2018. PMID: 29748949.
  18. Mesenchymal stem cells for doxorubicin-induced cardiomyopathy: Potential mechanisms and implications of heart stem cell debate. Front Pharma. 2019. PMID: 31258475.
  19. Peroxisome proliferator-activated receptors as therapeutic targets for heart failure. Biomed Pharmacother. 2017. PMID: 28886529.
  20. Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a meta-analysis. BMC Cardiovasc Disord. 2017. PMID: 28836953.
  21. Effects of Telestroke on Thrombolysis Times and Outcomes: A Meta-analysis. Prehosp Emerg Care. 2018. PMID: 29345529.
  22. Effects of Antioxidant Supplements on the Survival and Differentiation of Stem Cells. Oxid Med Cell Longev. 2017. PMID: 28770021.
  23. Regional versus local anesthesia for arteriovenous fistula creation in end-stage renal disease: a systematic review and meta-analysis. J Vasc Access. 2017. PMID: 28478618.
  24. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomed Pharma. 2017. PMID: 28460429.
  25. Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity. J Diabetes Res. 2017. PMID: 28286779.
  26. Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials. CNS Neurol Disord Drug Targets. 2017. PMID: 27978795.

Authored Pages

Retrieved from "https://www.wikidoc.org/index.php?title=Abdelrahman_Ibrahim_Abushouk&oldid=1596474"